# BraiN20® Medical Device in Suspected Acute Stroke Patients

Study · id `cardio:ct-nct06421337` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06421337](<https://clinicaltrials.gov/study/NCT06421337>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06421337

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 500 participants.

## Technical summary

Registry record NCT06421337. Allocation not applicable; no masking; primary purpose diagnostic. Start 2024-03-15 (actual); primary completion 2024-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 500 participants (planned count; ClinicalTrials.gov record NCT06421337, source copy `cardio:ctgov-nct06421337-2024-05-20`, retrieved 2026-10-26)
- Started: 2024-03-15 (actual) (ClinicalTrials.gov record NCT06421337, source copy `cardio:ctgov-nct06421337-2024-05-20`, retrieved 2026-10-26)
- Primary completion: 2024-12-31 (anticipated) (ClinicalTrials.gov record NCT06421337, source copy `cardio:ctgov-nct06421337-2024-05-20`, retrieved 2026-10-26)
- Completion: 2025-03-31 (anticipated) (ClinicalTrials.gov record NCT06421337, source copy `cardio:ctgov-nct06421337-2024-05-20`, retrieved 2026-10-26)
- Countries: Spain (ClinicalTrials.gov record NCT06421337, source copy `cardio:ctgov-nct06421337-2024-05-20`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06421337-2024-05-20`, retrieved 2026-10-26)

## The registry's words

- Brief title: BraiN20® Medical Device in Suspected Acute Stroke Patients
- Acronym: PROMISE-GLOB
- Condition: Acute Stroke
- Intervention (Device): BraiN20(R)
- Lead sponsor: Alicia Martínez Piñeiro
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)

## Provenance

Content hash: cc6e807de0a1ba26e91f5ae97adcde71fb3ae6e8466259d522a36bf67db39a44
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
